Emerging Ultrasonic Nebulizer Market To Witness Increased Revenue Upto US$ 218.3 Mn By 2024 Owing To Increasing Cases Of Chronic Respiratory Diseases
The global ultrasonic nebulizer market is gaining popularity owing to increasing prevalence of chronic respiratory diseases like asthma and chronic obstructive pulmonary disease. An ultrasonic nebulizer is a small, lightweight medical device used to administer medication in the form of a mist inhaled into the lungs. It works by using ultrasonic waves to break up liquids like saline solution and medication into small mist particles. This helps deliver medications directly to the lungs for conditions affecting breathing like asthma, cystic fibrosis,bronchitis, and pneumonia.
The Global Ultrasonic Nebulizer Market Size Is Estimated To Be Valued At US$ 218.3 Mn In 2024 And Is Expected To Exhibit A CAGR Of 5.9% Over The Forecast Period 2024-2031.
Ultrasonic nebulizers offer various advantages over other traditional nebulizers like compact size, wireless setup, noiseless operation and being more effective in drug delivery to the lungs. Furthermore, they come with advanced features like battery power, multiple voltage settings and mesh screens to produce consistent particle sizes. Their ability to administer asthma preventers and bronchodilators quickly and provide fast relief is a key factor fueling its demand among pulmonary patients. The Global Ultrasonic Nebulizer Market is driven by the growing geriatric population being prone to lung diseases and increasing awareness about home-based healthcare devices for efficient self-medication.
Key Takeaways
Key players operating in the ultrasonic nebulizer market are Philips Healthcare, Omron, PARI Medical, BD, Agilent Technologies, Airssential, Allied Healthcare Products, Briggs Healthcare, Carefusion, GF Health Products, Medline Industries, Medquip, Devilbiss Healthcare, Medisana, Precision Medical, Rossmax, Salvatore Robuschi, Shenzhen Shenkang, VENTA-Tec, And Walkmed.
The growing demand for home healthcare devices during Covid-19 is positively influencing the sales of ultrasonic nebulizers as they enable patients to self-administer drugs at home. Furthermore, the rising healthcare expenditure, especially in developing nations is increasing the affordability of such premium medical devices.
Manufacturers are focusing on technological advancements like the integration of ultrasonic nebulizers with smartphones. Such developments allow remote monitoring of medication use and treatment adherence through apps. This aids doctors in efficient diagnosis and therapy management of chronic respiratory patients.
Market Trends
Growing adoption of portable and wearable nebulizers - The market is witnessing the launch of compact, lightweight ultrasonic nebulizers that can be worn around the neck or attached to clothes. Their portability enables medication on-the-go for active patients.
Increased usage of mesh technology - Mesh screens with smaller pore sizes are able to produce finer mist particles for deeper lung penetration. This helps deliver drugs effectively to treat conditions like COPD.
Market Opportunities
Emerging economies in Asia Pacific and Latin America are expected to generate high demand for budget-friendly ultrasonic nebulizers due to growing pollution and smoking rates causing respiratory problems.
Integration of advanced technologies like Bluetooth connectivity and sensors allow monitoring of treatment compliance and medication usage patterns. This data could help physicians modify therapy for better outcomes.
Covid-19 Impact On The Global Ultrasonic Nebulizer Market
The COVID-19 pandemic has adversely impacted the growth of the global ultrasonic nebulizer market. The outbreak led to lockdowns imposed across various countries which disrupted the supply chain and halted production activities. This caused a decline in the sales of ultrasonic nebulizers owing to the closure of manufacturing facilities and unavailability of raw materials. There was shortage of devices across hospitals and clinics as priority was given to covid treatment. Restrictions on travel and transportation made it difficult to transport finished goods to customers on time. The demand from institutional end users like hospitals also reduced significantly as resources were diverted towards handling covid patients.
However, post pandemic recovery has boosted sales of ultrasonic nebulizers again. With resumption of economic activities and relaxation of lockdown norms, production and distribution channels have normalized. There is growing focus on preventive healthcare and respiratory disorders amid pandemic which is driving the market. The usage of nebulizer devices at home increased to self manage diseases like asthma. Manufacturers are developing portable units to make treatment accessible for home healthcare. Rising awareness about importance of respiratory health and technology advancements in devices are factors expected to support market growth in the coming years.
North America holds the major share of the global ultrasonic nebulizer market in terms of value owing to higher healthcare spending, growing geriatric population with respiratory conditions, and government initiatives to improve respiratory care infrastructure. Rising demand for portable ultrasound nebulizers for asthma and COPD treatment is driving the market in the region. Asia Pacific is identified as the fastest growing regional market with countries like China and India experiencing rapid economic development and increasing medical needs of large population base. Favorable initiatives by governments to strengthen healthcare systems and spread respiratory disorder awareness are contributing to market growth in Asia Pacific.
Europe accounts for a sizable share in the global ultrasonic nebulizer industry led by advanced healthcare infrastructure and supportive reimbursement framework. High prevalence of chronic respiratory diseases and improved access to diagnostic services and medical devices are fueling regional market expansion. Latin America and Middle East & Africa are also exhibiting steady demand for nebulizer devices owing to prevalence of respiratory illnesses like tuberculosis. Investments by international companies and technological innovations adapted for resource-poor settings are propelling market growth in these regions.
What are the key data covered in this Global Ultrasonic Nebulizer Market report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Global Ultrasonic Nebulizer Market's growth between 2024 and 2031.
:- Accurate calculation of the size of the Global Ultrasonic Nebulizer Market and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behavior
:- Global Ultrasonic Nebulizer Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market's competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Global Ultrasonic Nebulizer Market vendors
FAQ’s
Q.1 What are the main factors influencing the Global Ultrasonic Nebulizer market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Global Ultrasonic Nebulizer Market companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Global Ultrasonic Nebulizer market’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Get more insights on this topic: https://www.ukwebwire.com/global-ultrasonic-nebulizer-market-growth-and-demand/
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
Comments
0 comment